Genmab A/SGMABNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank93
3Y CAGR+47.8%
5Y CAGR+9.6%
Studio
Year-over-Year Change

Free cash flow yield

3Y CAGR
+47.8%/yr
vs +21.6%/yr prior
5Y CAGR
+9.6%/yr
Recent acceleration
Acceleration
+26.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20256.03%-23.3%
20247.86%+58.0%
20234.98%+166.2%
20221.87%+62.7%
20211.15%-69.9%
20203.82%+193.0%
20191.30%+52.1%
20180.86%-63.3%
20172.33%+455.8%
20160.42%-